Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9086034, 10 pages
https://doi.org/10.1155/2017/9086034
Research Article

The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats

1Graduate School, Beijing University of Chinese Medicine, No. 11, Bei San Huan Dong Lu, Chaoyang District, Beijing 100029, China
2Gastroenterology Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 1 Xi Yuan Yard Road, Haidian District, Beijing 100091, China
3The First Affiliated Hospital of Henan University of TCM, Zhengzhou, Henan 450000, China
4Department of Pharmaceutical Preparation, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 1 Xi Yuan Yard Road, Beijing 100091, China

Correspondence should be addressed to Fengyun Wang; moc.361@118yfw and Xudong Tang; moc.anis@yldxt

Received 18 April 2016; Accepted 14 December 2016; Published 26 February 2017

Academic Editor: Jiande D. Z. Chen

Copyright © 2017 Xiangxue Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Drossman, “The Functional Gastrointestinal Disorders and the Rome III Process,” Gastroenterology, vol. 130, no. 5, pp. 1377–1390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. P. Dunlop, D. Jenkins, K. R. Neal, and R. C. Spiller, “Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS,” Gastroenterology, vol. 125, no. 6, pp. 1651–1659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Dunlop, D. Jenkins, and R. C. Spiller, “Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome,” American Journal of Gastroenterology, vol. 98, no. 7, pp. 1578–1583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Spiller and K. Garsed, “Postinfectious Irritable Bowel Syndrome,” Gastroenterology, vol. 136, no. 6, pp. 1979–1988, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Zanini, C. Ricci, F. Bandera et al., “Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak,” American Journal of Gastroenterology, vol. 107, no. 6, pp. 891–899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Spiller and K. Garsed, “Infection, inflammation, and the irritable bowel syndrome,” Digestive and Liver Disease, vol. 41, no. 12, pp. 844–849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Barbara, V. Stanghellini, R. De Giorgio et al., “Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome,” Gastroenterology, vol. 126, no. 3, pp. 693–702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Vivinus-Nébot, R. Dainese, R. Anty et al., “Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells,” American Journal of Gastroenterology, vol. 107, no. 1, pp. 75–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Park, P.-L. Rhee, H. S. Kim et al., “Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome,” Journal of Gastroenterology and Hepatology, vol. 21, no. 1, pp. 71–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schemann and M. Camilleri, “Functions and imaging of mast cell and neural axis of the gut,” Gastroenterology, vol. 144, no. 4, pp. 698–704.e4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Fan, M.-Y. Qui, J.-J. Mei, G.-X. Shen, S.-L. Liu, and R. Chen, “Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis,” World Journal of Gastroenterology, vol. 11, no. 31, pp. 4800–4806, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-G. Hu, D. Xu, Y. Zhao et al., “The alleviating pain effect of aqueous extract from Tong-Xie-Yao-Fang, on experimental visceral hypersensitivity and its mechanism,” Biological and Pharmaceutical Bulletin, vol. 32, no. 6, pp. 1075–1079, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X. G. Hu and Z. H. Wang, “The clinic study of Tong-Xie-Yao-Fang on stagnation and spleen deficiency in 35 D-IBS patients,” Chinese Medical Journal, vol. 23, pp. 1075–1079, 2012. View at Google Scholar
  14. X. Hu, X. Zhang, B. Han, and W. Bei, “The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor,” BMC Complementary and Alternative Medicine, vol. 13, article no. 246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. V. Coutinho, P. M. Plotsky, M. Sablad et al., “Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 282, no. 2, pp. G307–G316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F.-Y. Wang, M. Su, Y.-Q. Zheng et al., “Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome,” Acta Pharmacologica Sinica, vol. 36, no. 6, pp. 708–715, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-Y. Qin, H.-T. Xiao, J. C. Y. Wu, B. M. Berman, J. J. Y. Sung, and Z.-X. Bian, “Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats,” World Journal of Gastroenterology, vol. 18, no. 20, pp. 2481–2492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. S. Mineur, C. Belzung, and W. E. Crusio, “Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice,” Behavioural Brain Research, vol. 175, no. 1, pp. 43–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Isingrini, V. Camus, A.-M. Le Guisquet, M. Pingaud, S. Devers, and C. Belzung, “Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice,” PLoS ONE, vol. 5, no. 4, Article ID e10404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. D. Al-Chaer, M. Kawasaki, and P. J. Pasricha, “A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development,” Gastroenterology, vol. 119, no. 5, pp. 1276–1285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Rex, J. P. Voigt, M. Voits, and H. Fink, “Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs,” Pharmacology Biochemistry and Behavior, vol. 59, no. 3, pp. 677–683, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-Q. Li, X.-Y. Wang, H.-F. Zhai et al., “Effects of early postnatal sibling deprivation on anxiety and vulnerability to cocaine in offspring rats,” Psychopharmacology, vol. 199, no. 2, pp. 245–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. El-Salhy, D. Gundersen, O. H. Gilja, J. G. Hatlebakk, and T. Hausken, “Is irritable bowel syndrome an organic disorder?” World Journal of Gastroenterology, vol. 20, no. 2, pp. 384–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Nystedt, K. Emilsson, C. Wahlestedt, and J. Sundelin, “Molecular cloning of a potential proteinase activated receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 20, pp. 9208–9212, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-Q. Long, J.-J. Tong, W. Qian, and X.-H. Hou, “Altered expression of intestinal cytokines in development of postinfectious irritable bowel syndrome mouse model,” Zhonghua yi xue za zhi, vol. 90, no. 34, pp. 2415–2419, 2010. View at Google Scholar · View at Scopus
  26. S. Foley, K. Garsed, G. Singh et al., “Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation,” Gastroenterology, vol. 140, no. 5, pp. 1434.e1–1443.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Vergnolle, N. W. Bunnett, K. A. Sharkey et al., “Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway,” Nature Medicine, vol. 7, no. 7, pp. 821–826, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Grundy, E. D. Al-Chaer, Q. Aziz et al., “Fundamentals of neurogastroenterology: basic science,” Gastroenterology, vol. 130, no. 5, pp. 1391–1411, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. M. Abraham, “Tryptase: potential role in airway inflammation and remodeling,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 282, no. 2, pp. L193–L196, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-H. He, “Key role of mast cells and their major secretory products in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 10, no. 3, pp. 309–318, 2004. View at Google Scholar · View at Scopus
  31. M. Ortiz Lucas, P. Saz Peiró, and J. J. Sebastián Domingo, “Irritable bowel syndrome immune hypothesis: part two: the role of cytokines,” Revista Española de Enfermedades Digestivas, vol. 102, no. 12, pp. 711–717, 2010. View at Publisher · View at Google Scholar
  32. C. Darkoh, L. Comer, G. Zewdie, S. Harold, N. Snyder, and H. L. DuPont, “Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome,” PLoS ONE, vol. 9, no. 3, Article ID e93144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Scalera, M. N. D. Di Minno, and G. Tarantino, “What does irritable bowel syndrome share with non-alcoholic fatty liver disease?” World Journal of Gastroenterology, vol. 19, no. 33, pp. 5402–5420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Nakagawa, A. Katsuya, S. Tanimoto et al., “Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats,” Neuroscience Letters, vol. 344, no. 3, pp. 197–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Levy, V. Kainz, R. Burstein, and A. M. Strassman, “Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity,” Brain, Behavior, and Immunity, vol. 26, no. 2, pp. 311–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. D. D. Metcalfe, D. Baram, and Y. A. Mekori, “Mast cells,” Physiological Reviews, vol. 77, no. 4, pp. 1033–1079, 1997. View at Google Scholar · View at Scopus
  37. A. Wald and D. Rakel, “Behavioral and complementary approaches for the treatment of irritable bowel syndrome,” Nutrition in Clinical Practice, vol. 23, no. 3, pp. 284–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Y. Carroll, S. M. O'Mahony, S. Grenham, J. F. Cryan, and N. P. Hyland, “Disodium cromoglycate reverses colonic visceral hypersensitivity and influences colonic ion transport in a stress-sensitive rat strain,” PLoS ONE, vol. 8, no. 12, Article ID e84718, 2013. View at Publisher · View at Google Scholar · View at Scopus